Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas

被引:79
作者
Getz, L
Kirkengen, AL
机构
[1] Univ Iceland, Dept Family Med, Reykjavik, Iceland
[2] Norwegian Univ Sci & Technol, Fac Med, N-7034 Trondheim, Norway
关键词
ultrasound screening; soft markers; chromosomal aberrations; nuchal translucency; Down syndrome; ethical dilemmas;
D O I
10.1016/S0277-9536(02)00200-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Fetal ultrasound screening has become routine practice in many western countries. During the last decade, such screening has led to frequent situations characterised by clinical uncertainty due to the disclosure of soft markers in the unborn child. Soft markers are minor anatomical variations indicating a somewhat increased likelihood that the fetus has a chromosomal aberration, most frequently trisomy 21 (Down syndrome). This paper presents the results of a comprehensive literature search of the National Library of Medicine with emphasis on the chronological development of scientific knowledge in relation to soft markers and the link between advancing imaging technology and clinical counselling dilemmas. An analysis of the literature makes evident that many ultrasound examiners have counselled individual pregnant women on the basis of insufficient data. Moral dilemmas have thus emerged as a direct result of advancing medical technology, and healthy fetal lives prove to have been lost due to invasive diagnostic testing aimed at resolving clinical uncertainty. Ultrasound examiners have warned against a policy of disclosing all findings of soft markers to expectant parents. but no exploration of experiential aspects linked to the disclosure of fetal soft markers has yet been published in the medical literature. The emotional reactions of mothers are important to consider given their potential impact on the biological development of the fetus. In conclusion, this paper stresses the need for paying close attention to the crucial distinction between technology development and technology implementation in relation to prenatal testing, Furthermore, it provides strong arguments for scrutinising the interface between prenatal testing and human experience. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2045 / 2057
页数:13
相关论文
共 114 条
[21]   The examination of the embryo and early fetus: how and by whom? [J].
Blaas, HGK .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 14 (03) :153-158
[22]   THE IMPACT OF BIOCHEMISTRY, BIOAVAILABILITY AND BIOACTIVITY ON THE SELECTION OF BIOREMEDIATION TECHNIQUES [J].
BLACKBURN, JW ;
HAFKER, WR .
TRENDS IN BIOTECHNOLOGY, 1993, 11 (08) :328-333
[23]   6-year experience of prenatal diagnosis in an unselected population in Oxford, UK [J].
Boyd, PA ;
Chamberlain, P ;
Hicks, NR .
LANCET, 1998, 352 (9140) :1577-1581
[24]  
BRICKER L, 2000, HLTH TECHNOLOGY ASSE, V4
[25]  
Bromley B, 1999, J ULTRAS MED, V18, P523
[26]  
BURGER J, 1993, PEDIATRICS, V91, P566
[27]   Maternal life event stress and congenital anomalies [J].
Carmichael, SL ;
Shaw, GM .
EPIDEMIOLOGY, 2000, 11 (01) :30-35
[28]   THE SORCERERS BROOM - MEDICINES RAMPANT TECHNOLOGY [J].
CASSELL, EJ .
HASTINGS CENTER REPORT, 1993, 23 (06) :32-39
[29]   Communal bereavement and the incidence of very low birthweight in Sweden [J].
Catalano, R ;
Hartig, T .
JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 2001, 42 (04) :333-341
[30]  
Chernikov SV, 1996, SOL SCI TECHNOL LIB, V3, P115